Notably, CPA variants have been associated with increased risk for prostate cancer in humans (Ross et al., 2009), which could be of interest in the context of reduced cancer susceptibility in whales compared with humans (de Magalhães, 2013). This evidence concerns the gene CPA1 and Familial prostate cancer.